Skip to main content
TARS $78.20 -0.61%
TARS logo
TARS · Tarsus Pharmaceuticals, Inc.
Track TARS — free
$78.20 -0.48 (-0.61%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$3.86B
Shares
49.31M
Volume · Nov 17 542.25K Avg daily vol (3M) 874.8K
All webcasts

Earnings call · FY2021 Q3

Tarsus Pharmaceuticals, Inc. (TARS) Q3 2021 Earnings Call

Concluded Nov 29, 2021
Nov 29, 2021
Period
FY2021 Q3
Runtime
—
Sources
2 artifacts
Revenue $1.24M
Diluted EPS -$0.76
Gross margin · derived Q4 94.8%
Net income -$15.70M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License And Service$708,000
Collaboration$532,000
Full-screen source Call document